In the last two years, at least a dozen platforms have closed with little warning. The disruption is not just inconvenience.
In the last two years, at least a dozen telehealth platforms have shut down, been acquired, or suspended operations — some with little or no warning to patients. When a telehealth platform closes, the disruption is not just an inconvenience. For patients who depend on that platform for ongoing medication — particularly controlled substances or GLP-1 weight loss drugs — a sudden shutdown can create a medical gap with real health consequences.
The telehealth market grew explosively during and after the pandemic, fueled by venture capital that expected pandemic-era utilization rates to continue indefinitely. When patient volumes normalized, many companies found themselves with burn rates that exceeded revenue. Common failure patterns include:
When a telehealth platform shuts down, your prescription does not transfer to a new provider automatically. Specifically:
The risk of platform shutdown is not a reason to avoid telehealth — it is a reason to choose providers with stability indicators and to maintain your own continuity plan:
Established GLP-1 program with consistent pricing and clinical support.
Plans from $130/mo (semaglutide)
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
GLP-1 clinical programs with ongoing monitoring and dose management.
From $297/mo · $399/mo at 7.5mg+
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
Direct-intake GLP-1 program with pharmacy fulfillment.
From $239/mo (semaglutide)
Paid link · Affiliate disclosure
⚕️ Compounded medications are not FDA-approved. They are prepared by state-licensed pharmacies under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
Some industry groups are pushing for standardized patient data portability in telehealth — the ability for patients to transfer their records and prescription history seamlessly between platforms. This does not yet exist at scale, but it is a feature worth asking about when evaluating providers.
In the interim, the platforms that handle shutdowns responsibly — providing advance notice, facilitating record access, and coordinating prescription transfers — build the kind of trust that sustains the industry. The ones that disappear overnight without communication damage telehealth credibility for everyone.
Telehealth platform instability is a real risk, particularly in the GLP-1 and men's health categories where many startups are competing for market share. The risk is manageable if you choose providers with stability indicators, maintain your own records, and never assume that any single platform will be permanent. Your health is yours. Make sure your health data is too.
Affiliate Disclosure: Virtual Health Visits earns commissions when readers sign up through certain links. This does not influence our coverage, rankings, or editorial independence. We review providers with and without affiliate programs equally.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication or treatment program.